e-learning
resources
Virtual 2021
05.09.2021
COVID – 19: treatments and predictive factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Correlation of CT severity score and Inflammatory markers to predict the disease severity in COVID 19 patients
A. Lonsane (Pune, India), R. Chopra (Pune, India), M. Jayamani (Chennai, India)
Source:
Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Session:
COVID – 19: treatments and predictive factors
Session type:
E-poster
Number:
819
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lonsane (Pune, India), R. Chopra (Pune, India), M. Jayamani (Chennai, India). Late Breaking Abstract - Correlation of CT severity score and Inflammatory markers to predict the disease severity in COVID 19 patients. 819
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients.
Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound
Year: 2020
Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Biomarkers in COPD patients: Relationship with severity indices
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract: Combining lung function and clinical severity score at two increases the predictability of current asthma at ten years
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018
Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Assessment of disease severity using imaging scores in pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Late Breaking Abstract - Associations between a COPD genetic risk score and lung structure on computed tomography (CT): SPIROMICS
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Inflammation markers: Dependence from severity of AECOPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Late Breaking Abstract - Validation of a clinical score predictive of SARS-CoV-2 infection in pneumonia inpatients
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Relationship between carotid wall thickness and multiple severity parameters in COPD patients
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017
Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade?
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept